Regional brain distribution of translocator protein using [ 11C]DPA-713 PET in individuals infected with HIV

Journal of NeuroVirology

Volumn 20, Issue 3, 2014, Pages 219-232

  Coughlin, Jennifer M ^a   Wang, Yuchuan ^b   Ma, Shuangchao ^a   Yue, Chen ^a   Kim, Pearl K ^a   Adams, Ashley V ^a   Roosa, Heidi V ^a   Gage, Kenneth L ^b   Stathis, Marigo ^a   Rais, Rana ^a   Rojas, Camilo ^a,f   McGlothan, Jennifer L ^c   Watkins, Crystal C ^a   Sacktor, Ned ^a   Guilarte, Tomas R ^c   Zhou, Yun ^b   Sawa, Akira ^a   Slusher, Barbara S ^a   Caffo, Brian ^a   Kassiou, Michael ^d,e   Endres, Christopher J ^b   Pomper, Martin G ^a,b   more..

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f Brain Science Institute Johns Hopkins Medical Institutions ^*  (United States)

Author keywords

HIV associated neurocognitive disorder; Microglia; Molecular neuroimaging; Neuro aids; Neuroinflammation; Translocator protein

Indexed keywords

ANTIRETROVIRUS AGENT; CARBON 11; CARRIER PROTEIN; DPA 713 C 11; RADIOLIGAND; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; ACETAMIDE DERIVATIVE; BIOLOGICAL MARKER; CARBON; N,N-DIETHYL-2-(2-(4-METHOXYPHENYL)-5,7-DIMETHYL-PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-ACETAMIDE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; TSPO PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUPRAMARGINAL GYRUS; TISSUE DISTRIBUTION; WHITE MATTER; AIDS DEMENTIA COMPLEX; BRAIN; GENETICS; GENOTYPE; METABOLISM; MICROGLIA; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PROCEDURES; SCINTISCANNING; VIROLOGY; YOUNG ADULT;

ACETAMIDES; ADULT; AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; BIOMARKERS; BRAIN; CARBON ISOTOPES; GENOTYPE; HUMANS; MICROGLIA; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; PYRAZOLES; PYRIMIDINES; RECEPTORS, GABA; YOUNG ADULT;

EID: 84905407732     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0239-5     Document Type: Article

References (38)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799 (Pubitemid 350059308)
2. Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M, Ryu YH, Imaizumi M, Hong J, Pike VW, Innis RB (2007) Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation. J NuclMed: Off Publ, Soc Nucl Med 48:2072-2079 (Pubitemid 350232319)
3. Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imag 35:2304-2319
4. Chauveau F, Van Camp N, Dolle F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B (2009) Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med: Off Publ, Soc Nucl Med 50:468-476
5. Chen Y, An H, Zhu H, Stone T, Smith JK, Hall C, Bullitt E, Shen D, Lin W (2009) White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+patients. NeuroImage 47:1154-1162
6. Chiang MC, Dutton RA, Hayashi KM, Lopez OL, Aizenstein HJ, Toga AW, Becker JT, Thompson PM (2007) 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. NeuroImage 34:44-60 (Pubitemid 44773796)
7. Churchill M, Nath A (2013) Where does HIV hide? A focus on the central nervous system. Curr Opin HIVand AIDS 8:165-169
8. Cysique LA, Moffat K, Moore DM, Lane TA, Davies NW, Carr A, Brew BJ, Rae C (2013) HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)HMRS study. PloS one 8:e61738
9. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med: Off Publ, Soc Nucl Med 50:1801-1807
10. Drugan RC (1996) Peripheral benzodiazepine receptors: molecular pharmacology to possible physiological significance in stress-induced hypertension. Clin Neuropharmacol 19:475-496
11. Endres CJ, Coughlin JM, Gage KL, Watkins CC, Kassiou M, Pomper MG (2012) Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans. J Nucl Med: Off Publ, Soc Nucl Med 53:330-335
12. Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, Reynolds A, Hilton J, Dannals RF, Kassiou M (2009) Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. J Nucl Med: Off Publ, Soc Nucl Med 50:1276-1282
13. Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, Winston A (2013) Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART; An 11C-PK11195 PET study. Aids
14. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51:629-650
15. Hammoud DA, Endres CJ, Chander AR, Guilarte TR, Wong DF, Sacktor NC, McArthur JC, Pomper MG (2005) Imaging glial cell activation with [11C]-R-PK11195 in patientswith AIDS. J Neurovirol 11:346-355 (Pubitemid 41614514)
16. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group C, Group H (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
17. Jucaite A, Cselenyi Z, Arvidsson A, Ahlberg G, Julin P, Varnas K, Stenkrona P, Andersson J, Halldin C, Farde L (2012) Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects. EJNMMI Res 2:15
18. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994 (Pubitemid 32335850)
19. Kreisl WC, Jenko KJ, Hines CS, Hyoung Lyoo C, Corona W, Morse CL, Zoghbi SS, Hyde T, Kleinman JE, Pike VW, McMahon FJ, Innis RB, Biomarkers Consortium PETRPT (2013a) A genetic polymorphismfor translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 33:53-58
20. Kreisl WC, Lyoo CH, McGwier M, Snow J, Jenko KJ, Kimura N, Corona W, Morse CL, Zoghbi SS, Pike VW, McMahon FJ, Turner RS, Innis RB, Biomarkers Consortium PETRPT (2013b) In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. Brain: J Neurol 136:2228-2238
21. Kuper M, Rabe K, Esser S, Gizewski ER, Husstedt IW, Maschke M, Obermann M (2011) Structural gray and white matter changes in patients with HIV. J Neurol 258:1066-1075
22. Lopez-Villegas D, Lenkinski RE, Frank I (1997) Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 94:9854-9859 (Pubitemid 27408154)
23. Marder K, Albert SM, McDermott MP, McArthur JC, Schifitto G, Selnes OA, Sacktor N, Stern Y, Palumbo D, Kieburtz K, Cohen B, Orme C, Epstein LG (2003) Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology 60:1467-1473 (Pubitemid 36554808)
24. Melrose RJ, Tinaz S, Castelo JM, Courtney MG, Stern CE (2008) Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Brain Res 188:337-347
25. Mizrahi R, Rusjan PM, Kennedy J, Pollock B, Mulsant B, Suridjan I, De Luca V, Wilson AA, Houle S (2012) Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 32:968-972
26. Mohamed MA, Lentz MR, Lee V, Halpern EF, Sacktor N, Selnes O, Barker PB, Pomper MG (2010) Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia. Radiology 254:577-586
27. Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, Innis RB, Pike VW, Reynolds R, Matthews PM, Parker CA (2011) Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med: Off Publ, Soc Nucl Med 52:24-32
28. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, StJean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP (2012) An 18-kDa translocator protein (TSPO) polymorphismexplains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 32:1-5
29. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trend Pharmacol Sci 27:402-409 (Pubitemid 44069585)
30. Rahmim A, Lenox M, Reader AJ, Michel C, Burbar Z, Ruth TJ, Sossi V (2004) Statistical list-mode image reconstruction for the high resolution research tomograph. Phys Med Biol 49:4239-4258 (Pubitemid 39302685)
31. Roberts ES, Chana G, Nguyen TB, Perera G, Landau S, Rabe-Hesketh S, Glass JD, McArthur J, Everall IP (2013) The spatial relationship between neurons and astrocytes in HIV-associated dementia. J Neurovirol 19:123-130
32. Rusjan PM, Wilson AA, Bloomfield PM, Vitcu I, Meyer JH, Houle S, Mizrahi R (2011) Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 31:1807-1816
33. Spudich S (2013) HIV and Neurocognitive Dysfunction. Curr HIV/AIDS Report 10:235-243
34. Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, Hammers A, Gerhard A, Hinz R, Tai YF, Brooks DJ (2007) Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med: Off Publ, Soc Nucl Med 48:158-167 (Pubitemid 47555390)
35. Venneti S, Lopresti BJ, Wiley CA (2006) The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 80:308-322 (Pubitemid 46107737)
36. Wang X, Foryt P, Ochs R, Chung JH, Wu Y, Parrish T, Ragin AB (2011) Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection. Brain Connect 1:207-217
37. Wiley CA, Lopresti BJ, Becker JT, Boada F, Lopez OL, Mellors J, Meltzer CC, Wisniewski SR, Mathis CA (2006) Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment. J Neurovirol 12:262-271 (Pubitemid 44382978)
38. Zhang Y, Wang M, Li H, Zhang H, Shi Y, Wei F, Liu D, Liu K, Chen D (2012) Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV-associated neurocognitive disorders. Brain Res 1458:1-11